Elham Roshandel

16PUBLICATIONS
39CO-AUTHORS
Innate immunityNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 03, 2026
Natural Killer Cell Immunotherapy After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia Patients: Phase I Clinical Trial.

|Jun 10, 2026
Natural Killer Cells: Dual Regulators and Therapeutic Targets in Multiple Sclerosis Immunopathogenesis.

|May 26, 2026
Induced Pluripotent Stem Cell-Derived NK Cells as an Off-the-Shelf Platform for Cancer Immunotherapy: Opportunities, Challenges, and Clinical Translation.

|Apr 27, 2026
The New Insight on the Significance of Vascular Endothelial Growth Factor in Anti-angiogenesis Therapy for Diffuse Large B Cell Lymphoma.

|Apr 01, 2026
Allogeneic CD56+ cell-based immunotherapy in a patient with Fanconi anemia developing acute myeloid leukemia.

Mehdi Bakhtiyari Dovvombaygi, Amin Shahbaz Ghasabeh, Shiva Eskandarian

|Mar 31, 2026
Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial.

Amin Shahbaz Ghasabeh, Amirhossein Izadpanah, Mehdi Bakhtiyaridovvombaygi

Pageof 3

Frequent Collaborators

5 joint publications

Maryam Mehravar

4 joint publications

Abbas Hajifathali

3 joint publications

Farzaneh Tavakoli

3 joint publications

Maryam Salimi